Search Results - steven+libutti

2 Results

Sort By:

Seventy Two Gene Model for 8 Thyroid Tumor Types

C10073: Seventy Two Gene Model for 8 Thyroid Tumor Types Value Proposition: Thyroid cancer represents 90% of all neuroendocrine malignancies with an estimated annual incidence of 122,800 cases worldwide. Currently, the most useful tool for the diagnosis of thyroid cancer is Fine-needle aspiration biopsy (FNA). This current method is extremely useful...

Published: 3/13/2025 | Inventor(s): Steven Libutti, Martha Zeiger, Nijaguna Prasad, Christopher Umbricht

Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Thyroid Cancer

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Endocrinology, Clinical and Disease Specializations > Oncology > Thyroid Cancer, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology

Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions

C04567: Diagnostic Tool for Diagnosing Benign Versus Malignant Thyroid Lesions Technical Details: Thyroid cancer represents 1% of all malignant diseases and it is estimated that 5-10% of the population will develop a clinically significant thyroid nodule during their lifetime. The best available test for thyroid nodule is fine needle aspiration biopsy...

Published: 3/13/2025 | Inventor(s): Steven Libutti, Chiara Mazzanti, Christopher Umbricht, Martha Zeiger

Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Thyroid Cancer